Autologous Alpha-2 Macroglobulin Rich Plasma
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous Alpha-2 Macroglobulin Rich Plasma, covering 2026-02-12 to 2026-02-12. Get the full timeline:
Most recent: Clinical Trial Update: Autologous Alpha-2 Macroglobulin Rich Plasma, Safety and Efficacy in Symptomatic Moderate Knee Osteoarthritis [Phase 1, Phase 2]